Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen

• 收藏
• 分享

专利权人:

Dennis Kim

发明人:

Dennis Kim,Michael Trautmann

申请号：

US12375734

公开号：

US08501693B2

申请日:

2007.08.06

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The present invention relates to altering the concentration of fibrinogen, specifically, for example, by decreasing fibrinogen concentration. The present invention also relates to methods for improving the cardiovascular risk profile of a subject by decreasing fibrinogen concentration.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/